Cardiologist and JAMA Deputy Editor Greg Curfman, MD, discusses the many changes in the new AHA/ACC/HRS atrial fibrillation guidelines with University of Chicago cardiologists Gaurav Upadhyay, MD, and Francis Alenghat, MD, PhD. Major changes include recommendations for the use of various agents for anticoagulation, catheter ablation, and left atrial appendage occlusion.

Read the article: Management of Patients With Atrial Fibrillation

Index of content:

2:19 Summary of the new ACC/AHA Atrial Fibrillation Guideline

8:04 Cost and efficacy of NOACs used to treat atrial fibrillation

11:42 Preference for specific NOACs

14:00 Rate vs rhythm control

20:00 How catheter ablation is performed

26:20 Anticoagulation requirements following ablation

31:23 How to achieve rate control

32:25 Left atrial appendage occlusion devices

36:29 New lifestyle recommendation

37:44 More about rate vs rhythm control

Update on Atrial Fibrillation: Review of the New AHA/ACC/HRS Treatment Guidelines